Ayala Pharmaceuticals Inc (ADXS)

[Biotechtrader07]

Looking forward to AACR data for PSA with updated survival and biomarker data, even though I don't expect mind blowing results, but it would be interesting to see how the 6 patients who are still living are doing.

Another key part is the planned investigator study for AXAL. Hopefully once the hold is lifted that study can be started. (Just a note here, they had this initially for Q1 announcement but I guess its pushed to H1 solely because of the hold.) I'm almost certain they have something lined up already if not they wouldn't state it like that on the presentation.

On the SP front, who thinks this would go down further? I have a feeling low 3s will be reached soon before going back over 4. MMs probably have a huge sell order here and will keep the share price down till news hits first half of the year.

On that note, even though it might be super risky I might average down when it does reach low 3s. 52 week low is 2.7 or something.